Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
The bill directs HHS to revise Medicare MDPP Expanded Model regulations by January 1, 2026 so entities offering only online Diabetes Prevention Program (MDPP) services can enroll as MDPP suppliers from 2026–2030. It sets the supplier administrative address as the Diabetes Prevention Recognition Program address, allows billing for beneficiaries located in a different State, and removes limits on how many times an individual may enroll in MDPP.
Progressives emphasize access, equity, and prevention benefits
Narrow, administrative healthcare access bill with bipartisan appeal, but may need CBO score and floor time.
The bill directs HHS to revise Medicare MDPP Expanded Model regulations by January 1, 2026 so entities offering only online Diabetes Prevention Program (MDPP) services can enroll as MDPP suppliers from 2026–2030.
It sets the supplier administrative address as the Diabetes Prevention Recognition Program address, allows billing for beneficiaries located in a different State, and removes limits on how many times an individual may enroll in MDPP.
Content is narrow and administratively focused, improving access; procedural hurdles, CBO cost implications, and legislative priorities moderate chances.
How solid the drafting looks.
Progressives emphasize access, equity, and prevention benefits
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize access, equity, and prevention benefits
Generally favorable: expands access to evidence-based diabetes prevention through virtual delivery and removes enrollment caps.
Sees potential to reduce health disparities if implemented with strong equity and quality safeguards.
Cautiously supportive: pragmatic step to modernize preventive services while maintaining program standards.
Wants measurable guardrails on quality, costs, and fraud prevention during the 2026–2030 period.
Skeptical: sees federal expansion of virtual supplier eligibility as increased regulatory reach and potential cost driver.
Prefers tighter limits, state roles, and stronger anti-fraud measures before backing.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrow and administratively focused, improving access; procedural hurdles, CBO cost implications, and legislative priorities moderate chances.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize access, equity, and prevention benefits
Content is narrow and administratively focused, improving access; procedural hurdles, CBO cost implications, and legislative priorities mod…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for PREVENT DIABETES Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.